Brief: Hemcheck Sweden Q2 Pre-Tax Loss Loss Narrows To SEK 1.2 Mln

Bio Vitos Pharma AB

30/08/2023 07:42

Aug 30 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q2 OPERATING REVENUE SEK 1.6 MILLION VERSUS SEK 0.2
MILLION YEAR
AGO
    * Q2 PRE-TAX LOSS SEK 1.2 MILLION VERSUS LOSS SEK 4.1
MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr4FP649 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))